(José Niño, Headline USA ) A recent study reveals a staggering financial burden on U.S. taxpayers, exceeding $1 billion yearly, due to a legal provision enabling pharmaceutical giants to deduct their marketing expenses. This finding, released last Tuesday by The Campaign for Sustainable RX Pricing (CSRxP), sheds light on the…
